Bruce Jacobs | executive |
Nello Mainolfi | executive |
Jared Gollob | executive |
Gospel Enyindah-Asonye | analyst |
Michael Schmidt | analyst |
Bradley Canino | analyst |
Chris Shibutani | analyst |
Marc Frahm | analyst |
Michael Kratky | analyst |
Eric Joseph | analyst |
Zhiqiang Shu | analyst |
Eliana Merle | analyst |
Timur Ivannikov | analyst |
Dingding Shi | analyst |
Jin Law | analyst |
Kalpit Patel | analyst |
Good morning, and welcome to the Kymera Therapeutics First Quarter 2023 Earnings Conference Call. [Operator Instructions] Please note that this event is being recorded today. I would now like to turn the conference over to the Chief Financial Officer, Bruce Jacobs. Please go ahead, sir.
Good morning, everyone, and welcome to the Kymera Therapeutics quarterly conference call.